Zoetis Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Zoetis heeft een totaal eigen vermogen van $5.2B en een totale schuld van $6.6B, wat de schuld-eigenvermogensverhouding op 126% brengt. De totale activa en totale passiva bedragen respectievelijk $14.4B en $9.1B. De EBIT Zoetis is $3.3B waardoor de rentedekking 26.1 is. Het heeft contanten en kortetermijnbeleggingen van $1.7B.
Belangrijke informatie
126.0%
Verhouding schuld/eigen vermogen
US$6.59b
Schuld
Rente dekkingsratio | 26.1x |
Contant | US$1.71b |
Aandelen | US$5.23b |
Totaal verplichtingen | US$9.12b |
Totaal activa | US$14.36b |
Recente financiële gezondheidsupdates
Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet
Oct 26Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Jul 16Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Dec 06Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly
Sep 04These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well
Apr 16Recent updates
Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A Buy
Nov 18Zoetis (NYSE:ZTS) Has A Pretty Healthy Balance Sheet
Oct 26Zoetis: A Solid Choice For The Young Dividend Growth Investor
Oct 09Do Zoetis' (NYSE:ZTS) Earnings Warrant Your Attention?
Oct 08Zoetis: Investing In Pet Health And Portfolio Wealth
Sep 26Are Investors Undervaluing Zoetis Inc. (NYSE:ZTS) By 23%?
Sep 20There's Reason For Concern Over Zoetis Inc.'s (NYSE:ZTS) Price
Aug 30Zoetis: Librela Sales Should Peak 200-300% Above Management's $1B Target
Aug 13Zoetis Q2 Earnings: Harvesting From DTC (Rating Upgrade)
Aug 07Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Jul 16Zoetis: A High-Quality Business And Fast Dividend Growth At A Reasonable Price
Jul 03Zoetis: Don't Fret Excessively Over The Animal Healthcare Leader
Jun 11A Look At The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Jun 10Zoetis (NYSE:ZTS) Ticks All The Boxes When It Comes To Earnings Growth
May 23Zoetis: Why The Focus On Companion Animal Segment Will Pay Off
May 22The Zoetis Inc. (NYSE:ZTS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 04Zoetis: Long-Term Buy Despite Safety Concerns
May 03Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment
Apr 15Zoetis Inc.'s (NYSE:ZTS) Shareholders Might Be Looking For Exit
Apr 12Zoetis: My Favorite Healthcare Stock Right Now
Mar 21Estimating The Fair Value Of Zoetis Inc. (NYSE:ZTS)
Mar 03Zoetis: Buy This High-Quality Dividend Growth Beast On Weakness
Feb 27Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns
Jan 10Some Confidence Is Lacking In Zoetis Inc.'s (NYSE:ZTS) P/E
Jan 01Zoetis' (NYSE:ZTS) Upcoming Dividend Will Be Larger Than Last Year's
Dec 14Does Zoetis (NYSE:ZTS) Have A Healthy Balance Sheet?
Dec 06Here's Why We Think Zoetis (NYSE:ZTS) Might Deserve Your Attention Today
Nov 18Zoetis: High-Quality Compounder With A Reasonable Price After Earnings
Nov 09Zoetis: Significant CapEx Investments For Long-Term Growth, But A Hold Now
Oct 26Zoetis Is An Impressive Healthcare Compounder
Sep 26Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Sep 25Here's Why Zoetis (NYSE:ZTS) Can Manage Its Debt Responsibly
Sep 04Zoetis: Pawses Pain, Librela OA Treatment Targets Furry Friends In The U.S.
Aug 22Should You Be Adding Zoetis (NYSE:ZTS) To Your Watchlist Today?
Aug 12Zoetis: My Dog Approves Of This Dividend Compounder
Jul 19Zoetis: A Purrfect Addition To Your Portfolio
Jun 22Does This Valuation Of Zoetis Inc. (NYSE:ZTS) Imply Investors Are Overpaying?
Jun 10These 4 Measures Indicate That Zoetis (NYSE:ZTS) Is Using Debt Reasonably Well
Apr 16Estimating The Intrinsic Value Of Zoetis Inc. (NYSE:ZTS)
Mar 10Zoetis rises on 2023 revenue forecast above estimates, Q4 profit in-line with consensus
Feb 14Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $6.3B ) ZTS } overtreffen de korte termijn passiva ( $1.7B ).
Langlopende schulden: De kortetermijnactiva van ZTS ( $6.3B ) dekken de langetermijnschulden ( $7.4B ) niet.
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 93.2% ) ZTS wordt als hoog beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van ZTS is de afgelopen 5 jaar gedaald van 241% naar 126%.
Schuldendekking: De schuld van ZTS wordt goed gedekt door de operationele kasstroom ( 44.7% ).
Rentedekking: De rentebetalingen op de schuld van ZTS worden goed gedekt door EBIT ( 26.1 x dekking).